Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.17
+0.14 (2.35%)
Nov 21, 2024, 3:04 PM EST - Market open
Coya Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$16.67
Upside
+170.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +191.73% | Nov 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +126.90% | Nov 7, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +126.90% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +191.73% | Sep 16, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +191.73% | Jun 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +126.90% | Jun 5, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +126.90% | May 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +126.90% | Apr 29, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $14 | Strong Buy | Maintains | $11 → $14 | +126.90% | Mar 20, 2024 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +353.81% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +78.28% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +78.28% | Jul 18, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +353.81% | Jul 18, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +78.28% | Jul 17, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +78.28% | Jun 8, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +353.81% | Jun 7, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.